Recent Digital Health Trends, Insights, and News – June 2026
AI enters a new phase of clinical care. Continuous monitoring gains momentum. Regulators push for greater accountability.
From next-generation wearables and smart diagnostics to AI-assisted clinical workflows and growing regulatory scrutiny around healthcare automation, the industry is moving beyond experimentation and closer to real-world scale and adoption.
Here’s a closer look at the latest digital health trends, innovations, and industry shifts shaping the future of virtual care.
Technology, News, and Insights
Smart Patch Enables Real-Time Monitoring for Diabetic Wounds
Researchers developed a smart wound patch capable of continuously monitoring diabetic wounds in real time by tracking biomarkers tied to inflammation and infection directly at the wound site. The technology could help clinicians identify complications earlier, reduce delayed interventions, and improve outcomes for patients with chronic diabetic wounds.
Read the full Georgia Tech article here >>
Smart Pills Could Redefine Gastrointestinal Diagnostics and Treatment
Researchers are advancing ingestible “smart pills” capable of monitoring inflammation, detecting disease markers, collecting tissue samples, and delivering medication directly within the gastrointestinal tract. Unlike traditional capsule endoscopy tools that only capture images, these next-generation devices are being designed to help respond to conditions inside the gut through real-time sensing and targeted drug delivery, potentially reducing the need for invasive procedures like endoscopies in the future.
Read the full Fox News article here >>
Wearable Ultrasound Could Transform Continuous Prenatal Monitoring
Scientists have developed UPatch, a wearable ultrasound patch designed to continuously monitor a baby in the womb for extended periods. The device provides real-time imaging of the fetus and tracks blood flow, including within moving structures such as the umbilical cord. While currently a proof-of-concept that requires external electronics and initial placement using conventional ultrasound, researchers say UPatch is the first technology of its kind and could help enable earlier detection of pregnancy complications through continuous fetal monitoring.
Read the full Guardian article here >>
Policy and Regulatory
Georgia Medicaid now covers lactation care via telehealth
Georgia Medicaid has expanded coverage to include lactation care delivered via telehealth, enhancing access to crucial maternal and infant health services. This policy update signifies growing recognition of telehealth's role in supporting specialized care and reducing barriers for those in rural areas with limited access to in-person providers.
Read the full WABE article here >>
FDA Rejects Proposal to Ease Oversight of AI Medical Devices
The FDA rejected a proposal that would have reduced regulatory oversight requirements for certain AI-enabled medical devices, signaling the agency’s continued focus on safety, transparency, and clinical accountability as healthcare AI adoption accelerates. This development highlights the growing challenge facing regulators: how to create oversight frameworks that can keep pace with rapidly evolving technologies while preserving patient safety and clinician confidence.
Read the full Telehealth.org article here >>
Supreme Court Preserves Telehealth Access to Mifepristone During Ongoing Legal Challenge
The Supreme Court temporarily preserved nationwide telehealth prescribing and mail delivery access for mifepristone while ongoing litigation continues over federal FDA rules allowing remote prescribing and pharmacy distribution of the medication. The case highlights growing legal tensions surrounding interstate telehealth prescribing authority, state abortion restrictions, federal drug regulation, and shield laws protecting clinicians who prescribe medications across state lines through virtual care platforms.
Read the full Telehealth.org article here >>
Lawmakers Push Back on CMS AI Prior Authorization Pilot
Federal lawmakers introduced resolutions seeking to overturn CMS’s WISeR pilot program, an AI-supported prior authorization initiative designed to streamline Medicare coverage reviews for select medical services. While CMS says the program aims to reduce unnecessary care and improve efficiency, critics have raised concerns around treatment delays, administrative complexity, and the role of AI in coverage decision-making.
Read the full Fierce Healthcare article here >>
Industry Conversations
Utah’s AI Prescribing Pilot Sparks Debate About the Future of Clinical AI
Utah’s AI prescribing pilot is becoming one of the healthcare industry’s most closely watched experiments as organizations, regulators, and clinicians debate how AI should be integrated into clinical decision-making. Newly released results showed the AI recommended prescription renewals in 72% of cases, with physicians later agreeing those renewals were appropriate 91% of the time. While supporters see the pilot as an example of how AI could reduce administrative burden and improve medication continuity, the program is also fueling broader conversations around oversight, accountability, and patient safety as AI becomes more embedded into care delivery.
Global Wellness Summit Highlights Women’s Longevity as a Defining 2026 Wellness Trend
The Global Wellness Summit’s newly released Future of Wellness Trends Report 2026 identified women’s longevity as one of the defining shifts shaping the future of healthcare and wellness. The report highlights growing industry recognition that women age differently than men, fueling increased focus on women-specific longevity strategies tied to ovarian aging, cardiovascular health, metabolic function, cognitive health, and strength training across every stage of life.
Growth, Funding, and Innovation
12 Deals Took 59% of All Digital Health Funding in Q1
Digital health funding remained “active but selective” in Q1 2026, with 59% of all venture capital concentrated in just 12 megadeals exceeding $100 million, according to Rock Health. Major raises included Whoop’s $575 million Series G at a $10.1 billion valuation, OpenEvidence’s $250 million Series D after surpassing $100 million in revenue, and women’s health platform Midi Health reaching unicorn status with a $100 million raise.
Read the full Fierce Healthcare article here >>
Fierce Healthcare Releases 2026 Digital Health Fundraising Tracker
Fierce Healthcare released its 2026 digital health fundraising tracker, highlighting where investors are placing bets across AI, care delivery infrastructure, automation, and chronic condition management. One of the largest recent raises came from virtual specialty care platform 9amHealth, which secured $26 million to expand its AI-enabled chronic care model focused on obesity, diabetes, hypertension, and other cardiometabolic conditions.
Read the full Fierce Healthcare article here >>
Oura’s IPO Filing Signals Growing Investor Confidence in Consumer Health Wearables
Oura’s confidential IPO filing is fueling broader industry conversations around the rapid growth of connected health wearables and the rising demand for personalized health intelligence. The smart ring company said it is on track to surpass five million paid members this quarter and has grown revenue 4x over the past two years, driven by expanding consumer interest in sleep, recovery, metabolic health, stress tracking, and AI-powered wellness insights.
Read the full CNBC article here >>
OpenLoop Resources & News
FDA PCAC Is Meeting to Review 7 Peptides July 2026: What It Means
The FDA’s upcoming July 2026 Pharmacy Compounding Advisory Committee (PCAC) meeting marks an important next step in the evolving regulatory conversation around peptides. During the public review, experts will evaluate seven peptides — including BPC-157, Semax, and Epitalon — for potential inclusion on the FDA’s 503A Bulks List, a key step toward future lawful compounding access. OpenLoop’s latest blog breaks down what the PCAC meeting actually means, what happens next in the FDA process, and what organizations should be watching as peptide regulations continue evolving.
Read the full OpenLoop blog here >>
The Top 10 Health Diagnostics Modern Telehealth Platforms Need
As virtual care matures, whole-health diagnostics are becoming a critical differentiator between transactional telehealth experiences and truly longitudinal care models, including comprehensive lab panels, sleep testing, hormone testing, cardiac monitoring, respiratory diagnostics, and mental health assessments. OpenLoop’s latest blog explores the top health diagnostics modern telehealth platforms should consider offering to differentiate, scale sustainably, and improve patient outcomes across virtual care delivery.
Read the full OpenLoop blog here >>
How to Market Your Peptide Therapy Program (Tips & Strategies)
As interest in peptide therapy continues rising, many brands are discovering one of the biggest marketing challenges isn’t just awareness — it’s education. Most patients are searching for solutions tied to energy, recovery, aging, performance, or longevity long before they ever search for the word “peptide.” OpenLoop’s latest blog explores the marketing strategies helping peptide therapy programs grow, from symptom-based awareness campaigns and educational content funnels to long-term wellness positioning designed to drive stronger patient engagement and retention.
Read the full OpenLoop blog here >>
*This content is intended for general informational purposes only and should not be construed as legal advice. For guidance on your specific situation, please consult a licensed attorney.